Abstract
Schistosomiasis parasitic infection (Schistosoma haematobium) is associated in some patients with bladder cancer. The production of cytokines such as tumor necrosis factor alpha (TNFα) is a key event of inflammation in human infectious disease and malignancy. TNFα has not been previously investigated from schistosomiasis infection and bladder malignancy. In this report we demonstrate that serum levels of TNFα are highly elevated in patients with schistosomiasis of urinary bladder (SB), schistosomiasis with carcinoma of urinary bladder (SCB), and carcinoma of urinary bladder without schistosomiasis (CB). Purified monocytes from bladder malignancy (SCB and CB) cultured without exogeneous stimuli release TNFα in the culture supernatants. However, lipopolysaccharides and concanavalin A stimulation of monocytes from these patients produced highly elevated levels of TNFα compared with normal controls. The findings that monocytes are the potent producers of TNFα in this malignancy may be a key observation implicating these cells in the pathophysiology of this disease. Furthermore, it was shown that serum TNFα levels correlated with the clinical staging of disease in both SCB and CB, with higher levels in T3 and T4 advanced-stage patients and low levels in T1 and T2 early-stage patients. These results suggest that monocyte abnormality and serum TNFα levels might be one of the factors contributing to the progression of disease.
Similar content being viewed by others
References
Raziuddin S, Shetty S, Ibrahim A, Patil K: Activated CD4 positive T lymphocytes and impaired cell-mediated immunity in patients with carcinoma of the urinary bladder with schistosomiasis. Cancer 65:931–939, 1990
Raziuddin S, Shetty S, Ibrahim A: T cell abnormality and defective interleukin-2 production in patients with carcinoma of the urinary bladder with schistosomiasis. J Clin Immunol 11:103–113, 1991
Sebai ZA: Schistosomiasis in Saudi Arabia. Ann Saudi Med 3:169–174, 1988
Bloom BR: Games parasites play: How parasites evade immune surveillance. Nature 279:21–26, 1979
Smithers SR, Doenhoff MJ: Schistosomiasis:In Immunology of Parasitic Infections, S Cohen, KS Warren (eds). Oxford, Blackwell Scientific, 1982, pp 527–607
Old LJ: Tumor necrosis factor. Science 230:630–632, 1985
Beutler B, Cerami A: Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 320:584–588, 1986
Dinarello CA, Mier JW: Current concepts. Lymphokines. N Engl J Med 317:940–945, 1987
Pober JS: Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am J Pathol 133:426–433, 1988
Balkwill F, Osborne R, Burke F, Tayloy S, Talbot D, Durbin H, Tavernier J, Fiers W: Evidence for tumor necrosis factor/cachetin production in cancer. Lancet 2:1229–1232, 1987
Hackett SP, Stevens DL: Streptoceccal toxic shock syndrome: Synthesis of tumor necrosis factor and interleukin 1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis 165:879–885, 1992
UICC, Union International Contrele Cancer TNM: Classification of Malignant Tumours, 3rd ed. Geneva, International Union against Cancer, 1978
Meager L, Leung H, Woolley J: Assays for tumor necrosis factor and related cytokines. J Immunol Methods 116:1–17, 1989
Vijaykumar E, Raziuddin S, Wardle EN: Plasma endotoxin in patients with trauma sepsis and severe haemorrhage. Clin Intens Care 2:4–9, 1991
Clark IA, Cowden WB, Butcher GA, Hunt NH: Possible roles of tumor necrosis factor in the pathology of malaria. Am J Pathol 129:192–199, 1987
Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue K, Cerami A, Brewster D, Greenwood B: TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated plasmodium falciparum malaria. Lancet 336:1201–1204, 1990
Barral-Netto M, Badaro R, Barral A, Almeida R, Santos S, Badaro F, Pedral-Sampaio D, Carvalho E, Falcoff E, Fal Coff R: Tumor necrosis factor (cahectin) in human visceral leishmaniasis. J Infect Dis 163:853–857, 1991
Nohynek H, Teppo A, Laire E, Leinonen M, Eskota J: Serum tumor necrosis factor and concentrations in children hospitalized for acute lower respiratory tract infection. J Infect Dis 163:1029–1032, 1991
Ammann AJ, Palladino M, Volberding P, Abrams D, Martin N, Conant M: Tumor necrosis factor alpha and beta in acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Clin Immunol 7:481–485, 1987
Cordingley FT, Hoffbrand AV, Heslop HE, Turner M, Bianchi A, Reittie J, Vyakaruam A, Meager A, Brenner MK: Tumor necrosis factor as an autocrine tumor growth factor for chronic B cell malignancies. Lancet 1:969–973, 1988
Lindemann A, Ludwig WD, Oster W, Mertelsmann R, Hermann F: High level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood 73:880–884, 1989
Lal RB, Rudolph DL: Constitutive production of interleukin-6 and tumor necrosis factor-α from spontaneously proliferating T cells in patients with human T cell lymphotropic virus type-III. Blood 78:571–574, 1991
Beutler B, Cerami A: The biology of Cachectin/TNFα. A primary mediator of the host response. Annu Rev Immunol 7:625–634, 1989
Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser JS and the Swiss-Dutch Immunoglobulin Study Group: High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value and interplay with other cytokines. Am J Med 91:23–29, 1991
Tracey KJ, Fong Y, Hesse DG: Anti-Cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330:662–664, 1987
Barnes PF, Fong SJ, Brennan PJ, Twomey P, Mazumder A, Modlin RL: Local production of tumor necrosis factor and IFN-γ in tuberculosis pleuritis. J Immunol 145:149–154, 1990
Titus RG, Sherry B, Cerami A: Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med 6:2097–2104, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Raziuddin, S., Masihuzzaman, M., Shetty, S. et al. Tumor necrosis factor alpha production in schistosomiasis with carcinoma of urinary bladder. J Clin Immunol 13, 23–29 (1993). https://doi.org/10.1007/BF00920632
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00920632